Minimed Group (MMED) closed at $18.85 on November 3, 2026, down 0.3% from the previous close, on volume of 5,329,074 shares (30-day average 13,219,123).
Data as of November 3, 2026.
3-Nov-2026
MiniMed Appoints Dr. David Segal as Chief Medical Officer
PRNewswire (Tue, 3-Nov 9:20 AM ET)
William Blair refreshes stock Conviction List with 5 additions, 3 removals
Seeking Alpha News (Mon, 2-Nov 8:56 AM ET)
Medtronic Completes Separation of MiniMed Group, Inc.
PRNewswire (Thu, 15-Oct 10:01 AM ET)
MiniMed Completes Separation from Medtronic
PRNewswire (Thu, 15-Oct 10:01 AM ET)
Market Chameleon (Wed, 14-Oct 7:39 AM ET)
Medtronic Announces Final Results of MiniMed Group, Inc. Exchange Offer
PRNewswire (Wed, 14-Oct 8:00 AM ET)
MiniMed (MMED) Exchange Offer Was Oversubscribed as Medtronic Moves to Exit Its Remaining Stake
Market Chameleon (Mon, 12-Oct 5:38 AM ET)
Medtronic Announces Preliminary Results of MiniMed Group, Inc. Exchange Offer
PRNewswire (Mon, 12-Oct 8:45 AM ET)
Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc.
PRNewswire (Wed, 7-Oct 5:31 PM ET)
PRNewswire (Mon, 5-Oct 7:08 AM ET)
While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.
Minimed Group trades on the NASDAQ stock market under the symbol MMED.
As of November 3, 2026, MMED stock price declined to $18.85 with 5,329,074 million shares trading.
MMED has a beta of 0.51, meaning it tends to be less sensitive to market movements. MMED has a correlation of 0.01 to the broad based SPY ETF.
MMED has a market cap of $5.30 billion. This is considered a Mid Cap stock.
Last quarter Minimed Group reported $843 million in Revenue and $.00 earnings per share. This beat revenue expectation by $15 million and missed earnings estimates by -$.09.
The top ETF exchange traded funds that MMED belongs to (by Net Assets): IWM, IWN, SCHA, FPX, FESM.
MMED support price is $18.21 and resistance is $19.59 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MMED shares will trade within this expected range on the day.
